-
1
-
-
78751621217
-
Evolving epidemiology of hepatitis C virus
-
Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-15.
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 107-115
-
-
Lavanchy, D.1
-
2
-
-
84867288022
-
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965
-
Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61: 1-32.
-
(2012)
MMWR Recomm Rep
, vol.61
, pp. 1-32
-
-
Smith, B.D.1
Morgan, R.L.2
Beckett, G.A.3
Falck-Ytter, Y.4
Holtzman, D.5
Teo, C.G.6
Jewett, A.7
Baack, B.8
Rein, D.B.9
Patel, N.10
Alter, M.11
Yartel, A.12
Ward, J.W.13
-
3
-
-
66449092942
-
HCV genotypes in Sicily: Is there any evidence of a shift?
-
Pizzillo P, Almasio PL, Ferraro D, Craxi A, Di Stefano R. HCV genotypes in Sicily: is there any evidence of a shift? J Med Virol 2009; 81: 1040-6.
-
(2009)
J Med Virol
, vol.81
, pp. 1040-1046
-
-
Pizzillo, P.1
Almasio, P.L.2
Ferraro, D.3
Craxi, A.4
Di Stefano, R.5
-
4
-
-
84983122789
-
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: Evidence for a vanishing infection
-
Guadagnino V, Stroffolini T, Caroleo B, Menniti Ippolito F, Rapicetta M, Ciccaglione AR, Chionne P, Madonna E, Costantino A, De Sarro G, Foca A, Lentini M, Staltari O. Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis 2013; 45: 403-7.
-
(2013)
Dig Liver Dis
, vol.45
, pp. 403-407
-
-
Guadagnino, V.1
Stroffolini, T.2
Caroleo, B.3
Menniti Ippolito, F.4
Rapicetta, M.5
Ciccaglione, A.R.6
Chionne, P.7
Madonna, E.8
Costantino, A.9
de Sarro, G.10
Foca, A.11
Lentini, M.12
Staltari, O.13
-
5
-
-
12644279860
-
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy
-
Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A, Piazza M. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-11.
-
(1997)
Hepatology
, vol.26
, pp. 1006-1011
-
-
Guadagnino, V.1
Stroffolini, T.2
Rapicetta, M.3
Costantino, A.4
Kondili, L.A.5
Menniti-Ippolito, F.6
Caroleo, B.7
Costa, C.8
Griffo, G.9
Loiacono, L.10
Pisani, V.11
Foca, A.12
Piazza, M.13
-
6
-
-
84878750736
-
Acute hepatitis C in patients undergoing hemodialysis: Experience with high-dose interferon therapy
-
Gentile I, Di Flumeri G, Scarica S, Frangiosa A, Foggia M, Reynaud L, Borgia G. Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy. Minerva Urol Nefrol 2013; 65: 83-4.
-
(2013)
Minerva Urol Nefrol
, vol.65
, pp. 83-84
-
-
Gentile, I.1
Di Flumeri, G.2
Scarica, S.3
Frangiosa, A.4
Foggia, M.5
Reynaud, L.6
Borgia, G.7
-
7
-
-
84881451656
-
Concomitant interferonalpha and chemotherapy in hepatitis C and colorectal cancer: A case report
-
Gentile I, De Stefano A, Di Flumeri G, Buonomo AR, Carlomagno C, Morisco F, De Placido S, Borgia G. Concomitant interferonalpha and chemotherapy in hepatitis C and colorectal cancer: a case report. In Vivo 2013; 27: 527-9.
-
(2013)
In Vivo
, vol.27
, pp. 527-529
-
-
Gentile, I.1
de Stefano, A.2
Di Flumeri, G.3
Buonomo, A.R.4
Carlomagno, C.5
Morisco, F.6
de Placido, S.7
Borgia, G.8
-
8
-
-
0030928695
-
Hepatitis C: The clinical spectrum of disease
-
Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997; 26: 15S-20S.
-
(1997)
Hepatology
, vol.26
-
-
Hoofnagle, J.H.1
-
9
-
-
10744225097
-
-
Global burden of disease (GBD) for hepatitis C
-
Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 20-9.
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 20-29
-
-
-
10
-
-
84877647206
-
A simple noninvasive score based on routine parameters can predict liver cirrhosis in patients with chronic Hepatitis C
-
Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N, Borgia G. A simple noninvasive score based on routine parameters can predict liver cirrhosis in patients with chronic Hepatitis C. Hepat Mon 2013; 13: e8352.
-
(2013)
Hepat Mon
, vol.13
-
-
Gentile, I.1
Coppola, N.2
Pasquale, G.3
Liuzzi, R.4
D'armiento, M.5
Di Lorenzo, M.E.6
Capoluongo, N.7
Buonomo, A.R.8
Sagnelli, E.9
Morisco, F.10
Caporaso, N.11
Borgia, G.12
-
11
-
-
84892722703
-
Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection
-
Gentile I, Meola M, Buonomo AR, Minei G, Coppola N, Foggia M, Ferruzzi F, Fratellanza G, Scarpato N, Borgia G. Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection. In Vivo 2013; 27: 773-7.
-
(2013)
In Vivo
, vol.27
, pp. 773-777
-
-
Gentile, I.1
Meola, M.2
Buonomo, A.R.3
Minei, G.4
Coppola, N.5
Foggia, M.6
Ferruzzi, F.7
Fratellanza, G.8
Scarpato, N.9
Borgia, G.10
-
12
-
-
35648970573
-
Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin
-
Braks RE, Ganne-Carrie N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, Pol S, Trinchet JC. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin. World J Gastroenterol 2007; 13: 5648-53.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 5648-5653
-
-
Braks, R.E.1
Ganne-Carrie, N.2
Fontaine, H.3
Paries, J.4
Grando-Lemaire, V.5
Beaugrand, M.6
Pol, S.7
Trinchet, J.C.8
-
13
-
-
4644224871
-
Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy
-
Tsuda N, Yuki N, Mochizuki K, Nagaoka T, Yamashiro M, Omura M, Hikiji K, Kato M. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol 2004; 74: 406-13.
-
(2004)
J Med Virol
, vol.74
, pp. 406-413
-
-
Tsuda, N.1
Yuki, N.2
Mochizuki, K.3
Nagaoka, T.4
Yamashiro, M.5
Omura, M.6
Hikiji, K.7
Kato, M.8
-
14
-
-
77951648047
-
Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
-
Gentile I, Borgia G. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis. J Hepatol 2010; 52: 778.
-
(2010)
J Hepatol
, vol.52
, pp. 778
-
-
Gentile, I.1
Borgia, G.2
-
15
-
-
33947360829
-
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
-
Bruno S, Stroffolini T, Colombo M, Bollani S, Benvegnu L, Mazzella G, Ascione A, Santantonio T, Piccinino F, Andreone P, Mangia A, Gaeta GB, Persico M, Fagiuoli S, Almasio PL. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 2007; 45: 579-87.
-
(2007)
Hepatology
, vol.45
, pp. 579-587
-
-
Bruno, S.1
Stroffolini, T.2
Colombo, M.3
Bollani, S.4
Benvegnu, L.5
Mazzella, G.6
Ascione, A.7
Santantonio, T.8
Piccinino, F.9
Andreone, P.10
Mangia, A.11
Gaeta, G.B.12
Persico, M.13
Fagiuoli, S.14
Almasio, P.L.15
-
16
-
-
65449136656
-
Diagnosis, management, and treatment of hepatitis C: An update
-
Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.
-
(2009)
Hepatology
, vol.49
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
Seeff, L.B.4
-
17
-
-
35148896751
-
HCV-related autoimmune and neoplastic disorders: The HCV syndrome
-
Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39: S13-21.
-
(2007)
Dig Liver Dis
, vol.39
-
-
Ferri, C.1
Antonelli, A.2
Mascia, M.T.3
Sebastiani, M.4
Fallahi, P.5
Ferrari, D.6
Pileri, S.A.7
Zignego, A.L.8
-
18
-
-
84888105681
-
Hepatitis C virus and type 1 diabetes
-
Fallahi P, Di Domenicantonio A, Mazzi V, Santini F, Fabiani S, Sebastiani M, Zignego AL, Ferri C, Antonelli A. Hepatitis C virus and type 1 diabetes. Clin Ter. 2013; 164: 437-44.
-
(2013)
Clin Ter
, vol.164
, pp. 437-444
-
-
Fallahi, P.1
Di Domenicantonio, A.2
Mazzi, V.3
Santini, F.4
Fabiani, S.5
Sebastiani, M.6
Zignego, A.L.7
Ferri, C.8
Antonelli, A.9
-
19
-
-
84887924285
-
Erectile dysfunction in patients with chronic viral hepatitis: A systematic review of the literature
-
Fusco F, D'Anzeo G, Rossi A, Sciorio C, Buonomo AR, dEmmanuele di Villa Bianca R, Borgia G, Mirone V, Gentile I. Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature. Expert Opin Pharmacother 2013; 14: 2533-44.
-
(2013)
Expert Opin Pharmacother
, vol.14
, pp. 2533-2544
-
-
Fusco, F.1
D'anzeo, G.2
Rossi, A.3
Sciorio, C.4
Buonomo, A.R.5
dEmmanuele di Villa Bianca, R.6
Borgia, G.7
Mirone, V.8
Gentile, I.9
-
20
-
-
84877795646
-
Sustained virological response: A milestone in the treatment of chronic hepatitis C
-
Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N. Sustained virological response: A milestone in the treatment of chronic hepatitis C. World J Gastroenterol 2013; 19: 2793-8.
-
(2013)
World J Gastroenterol
, vol.19
, pp. 2793-2798
-
-
Morisco, F.1
Granata, R.2
Stroffolini, T.3
Guarino, M.4
Donnarumma, L.5
Gaeta, L.6
Loperto, I.7
Gentile, I.8
Auriemma, F.9
Caporaso, N.10
-
21
-
-
84871109075
-
Efficacy of Pegylated interferon alpha-2a and alpha-2b in patients with genotype 1 chronic hepatitis C: A meta-analysis
-
Coppola N, Pisaturo M, Tonziello G, Sagnelli C, Sagnelli E, Angelillo IF. Efficacy of Pegylated interferon alpha-2a and alpha-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis. BMC Infect Dis 2012; 12: 1471-2334.
-
(2012)
BMC Infect Dis
, vol.12
, pp. 1471-2334
-
-
Coppola, N.1
Pisaturo, M.2
Tonziello, G.3
Sagnelli, C.4
Sagnelli, E.5
Angelillo, I.F.6
-
22
-
-
1542378867
-
Peginterferonalpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
-
Hadziyannis SJ, Sette H, Jr., Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H, Jr., Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. Peginterferonalpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55.
-
(2004)
Ann Intern Med
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
Balan, V.4
Diago, M.5
Marcellin, P.6
Ramadori, G.7
Bodenheimer Jr., H.8
Bernstein, D.9
Rizzetto, M.10
Zeuzem, S.11
Pockros, P.J.12
Lin, A.13
Ackrill, A.M.14
-
23
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr., Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr., F.L.6
Haussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
24
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa- 2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa- 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
25
-
-
84896126011
-
Prediction of sustained virologic responses to combination therapy of pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C infection
-
Ismail MH. Prediction of sustained virologic responses to combination therapy of pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C infection. J Family Community Med 2013; 20: 35-40.
-
(2013)
J Family Community Med
, vol.20
, pp. 35-40
-
-
Ismail, M.H.1
-
26
-
-
84881530517
-
Metabolic factors and chronic hepatitis C: A complex interplay
-
Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E, Petta S. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int 2013; 564-645: 17.
-
(2013)
Biomed Res Int
, vol.17
, pp. 564-645
-
-
Macaluso, F.S.1
Maida, M.2
Minissale, M.G.3
Li Vigni, T.4
Attardo, S.5
Orlando, E.6
Petta, S.7
-
27
-
-
79954669573
-
Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
-
Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011; 54: 887-93.
-
(2011)
J Hepatol
, vol.54
, pp. 887-893
-
-
Lange, C.M.1
Bojunga, J.2
Ramos-Lopez, E.3
von Wagner, M.4
Hassler, A.5
Vermehren, J.6
Herrmann, E.7
Badenhoop, K.8
Zeuzem, S.9
Sarrazin, C.10
-
28
-
-
58149484038
-
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: A prospective study
-
Borgia G, Gentile I, Fortunato G, Borrelli F, Borelli S, de Caterina M, Di Taranto MD, Simone M, Borgia F, Viola C, Reynaud L, Cerini R, Sacchetti L. Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. Liver Int 2009; 29: 248-52.
-
(2009)
Liver Int
, vol.29
, pp. 248-252
-
-
Borgia, G.1
Gentile, I.2
Fortunato, G.3
Borrelli, F.4
Borelli, S.5
de Caterina, M.6
Di Taranto, M.D.7
Simone, M.8
Borgia, F.9
Viola, C.10
Reynaud, L.11
Cerini, R.12
Sacchetti, L.13
-
29
-
-
0035990966
-
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection
-
Distante S, Bjoro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver 2002; 22: 269-75.
-
(2002)
Liver
, vol.22
, pp. 269-275
-
-
Distante, S.1
Bjoro, K.2
Hellum, K.B.3
Myrvang, B.4
Berg, J.P.5
Skaug, K.6
Raknerud, N.7
Bell, H.8
-
30
-
-
84870609448
-
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
-
Del Campo JA, Ampuero J, Rojas L, Conde M, Rojas A, Maraver M, Millan R, Garcia-Valdecasas M, Garcia-Lozano JR, Gonzalez- Escribano MF, Romero-Gomez M. Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism. Aliment Pharmacol Ther 2013; 37: 74-80.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 74-80
-
-
Del Campo, J.A.1
Ampuero, J.2
Rojas, L.3
Conde, M.4
Rojas, A.5
Maraver, M.6
Millan, R.7
Garcia-Valdecasas, M.8
Garcia-Lozano, J.R.9
Gonzalez-Escribano, M.F.10
Romero-Gomez, M.11
-
31
-
-
79960824576
-
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis
-
Deltenre P, Louvet A, Lemoine M, Mourad A, Fartoux L, Moreno C, Henrion J, Mathurin P, Serfaty L. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol 2011; 55: 1187-94.
-
(2011)
J Hepatol
, vol.55
, pp. 1187-1194
-
-
Deltenre, P.1
Louvet, A.2
Lemoine, M.3
Mourad, A.4
Fartoux, L.5
Moreno, C.6
Henrion, J.7
Mathurin, P.8
Serfaty, L.9
-
32
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
Urban, T.J.6
Heinzen, E.L.7
Qiu, P.8
Bertelsen, A.H.9
Muir, A.J.10
Sulkowski, M.11
McHutchison, J.G.12
Goldstein, D.B.13
-
33
-
-
70449601851
-
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial
-
Gentile I, Viola C, Paesano L, D'Onofrio M, D'Agostino E, Cerini R, Borrelli F, Piazza M, Borgia G. Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. J Clin Apher 2009; 24: 190-6.
-
(2009)
J Clin Apher
, vol.24
, pp. 190-196
-
-
Gentile, I.1
Viola, C.2
Paesano, L.3
D'onofrio, M.4
D'agostino, E.5
Cerini, R.6
Borrelli, F.7
Piazza, M.8
Borgia, G.9
-
34
-
-
84873029732
-
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients
-
Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients. Cochrane Database Syst Rev 2012; 12.
-
(2012)
Cochrane Database Syst Rev
, pp. 12
-
-
Katz, L.H.1
Goldvaser, H.2
Gafter-Gvili, A.3
Tur-Kaspa, R.4
-
35
-
-
79961234860
-
Treatment extension benefits HCV genotype 1 patients without rapid virological response: A systematic review
-
Gevers TJ, Slavenburg S, van Oijen MG, Drenth JP. Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review. Neth J Med 2011; 69: 216-21.
-
(2011)
Neth J Med
, vol.69
, pp. 216-221
-
-
Gevers, T.J.1
Slavenburg, S.2
van Oijen, M.G.3
Drenth, J.P.4
-
36
-
-
77950602195
-
Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance
-
Khattab M, Emad M, Abdelaleem A, Eslam M, Atef R, Shaker Y, Hamdy L. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. Liver international: official journal of the International Association for the Study of the Liver 2010; 30: 447-54.
-
(2010)
Liver International: Official Journal of the International Association For the Study of the Liver
, vol.30
, pp. 447-454
-
-
Khattab, M.1
Emad, M.2
Abdelaleem, A.3
Eslam, M.4
Atef, R.5
Shaker, Y.6
Hamdy, L.7
-
37
-
-
84857532001
-
Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients
-
Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients. World J Gastroenterol 2012; 18: 800-5.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 800-805
-
-
Nimer, A.1
Mouch, A.2
-
38
-
-
83755196636
-
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients
-
Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 2011; 17: 5184-90.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 5184-5190
-
-
Abu-Mouch, S.1
Fireman, Z.2
Jarchovsky, J.3
Zeina, A.R.4
Assy, N.5
-
39
-
-
84896959418
-
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
-
in press. PMID: 24081499, DOI: 10.1007/s10096-013-1985-7
-
Coppola N, Marrone A, Pisaturo M, Starace M, Signoriello G, Gentile I, Adinolfi LE, Sagnelli E, Zampino R. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. Eur J Clin Microbiol Infect Dis 2013 in press. PMID: 24081499, DOI: 10.1007/s10096-013-1985-7.
-
(2013)
Eur J Clin Microbiol Infect Dis
-
-
Coppola, N.1
Marrone, A.2
Pisaturo, M.3
Starace, M.4
Signoriello, G.5
Gentile, I.6
Adinolfi, L.E.7
Sagnelli, E.8
Zampino, R.9
-
40
-
-
80053339008
-
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
-
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.
-
(2011)
Hepatology
, vol.54
, pp. 1433-1444
-
-
Ghany, M.G.1
Nelson, D.R.2
Strader, D.B.3
Thomas, D.L.4
Seeff, L.B.5
-
41
-
-
79959381354
-
Telaprevir for retreatment of HCV infection
-
Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P, Nevens F, Mullhaupt B, Pockros P, Terg R, Shouval D, van Hoek B, Weiland O, Van Heeswijk R, De Meyer S, Luo D, Boogaerts G, Polo R, Picchio G, Beumont M. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364: 2417-28.
-
(2011)
N Engl J Med
, vol.364
, pp. 2417-2428
-
-
Zeuzem, S.1
Andreone, P.2
Pol, S.3
Lawitz, E.4
Diago, M.5
Roberts, S.6
Focaccia, R.7
Younossi, Z.8
Foster, G.R.9
Horban, A.10
Ferenci, P.11
Nevens, F.12
Mullhaupt, B.13
Pockros, P.14
Terg, R.15
Shouval, D.16
van Hoek, B.17
Weiland, O.18
van Heeswijk, R.19
de Meyer, S.20
Luo, D.21
Boogaerts, G.22
Polo, R.23
Picchio, G.24
Beumont, M.25
more..
-
42
-
-
79959438789
-
Telaprevir for previously untreated chronic hepatitis C virus infection
-
Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364: 2405-16.
-
(2011)
N Engl J Med
, vol.364
, pp. 2405-2416
-
-
Jacobson, I.M.1
McHutchison, J.G.2
Dusheiko, G.3
Di Bisceglie, A.M.4
Reddy, K.R.5
Bzowej, N.H.6
Marcellin, P.7
Muir, A.J.8
Ferenci, P.9
Flisiak, R.10
George, J.11
Rizzetto, M.12
Shouval, D.13
Sola, R.14
Terg, R.A.15
Yoshida, E.M.16
Adda, N.17
Bengtsson, L.18
Sankoh, A.J.19
Kieffer, T.L.20
George, S.21
Kauffman, R.S.22
Zeuzem, S.23
more..
-
43
-
-
79953173221
-
Boceprevir for untreated chronic HCV genotype 1 infection
-
Poordad F, McCone J, Jr., Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-206.
-
(2011)
N Engl J Med
, vol.364
, pp. 1195-1206
-
-
Poordad, F.1
McCone Jr., J.2
Bacon, B.R.3
Bruno, S.4
Manns, M.P.5
Sulkowski, M.S.6
Jacobson, I.M.7
Reddy, K.R.8
Goodman, Z.D.9
Boparai, N.10
Dinubile, M.J.11
Sniukiene, V.12
Brass, C.A.13
Albrecht, J.K.14
Bronowicki, J.P.15
-
44
-
-
79953176289
-
Boceprevir for previously treated chronic HCV genotype 1 infection
-
Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-17.
-
(2011)
N Engl J Med
, vol.364
, pp. 1207-1217
-
-
Bacon, B.R.1
Gordon, S.C.2
Lawitz, E.3
Marcellin, P.4
Vierling, J.M.5
Zeuzem, S.6
Poordad, F.7
Goodman, Z.D.8
Sings, H.L.9
Boparai, N.10
Burroughs, M.11
Brass, C.A.12
Albrecht, J.K.13
Esteban, R.14
-
45
-
-
84883404339
-
A novel promising therapeutic option against hepatitis C virus: An oral nucleotide NS5B polymerase inhibitor sofosbuvir
-
Gentile I, Borgia F, Buonomo AR, Castaldo G, Borgia G. A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr Med Chem 2013; 20: 3733-42.
-
(2013)
Curr Med Chem
, vol.20
, pp. 3733-3742
-
-
Gentile, I.1
Borgia, F.2
Buonomo, A.R.3
Castaldo, G.4
Borgia, G.5
-
46
-
-
84877730954
-
Sofosbuvir for previously untreated chronic hepatitis C infection
-
Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR, Jacobson IM, Kowdley KV, Nyberg L, Subramanian GM, Hyland RH, Arterburn S, Jiang D, McNally J, Brainard D, Symonds WT, McHutchison JG, Sheikh AM, Younossi Z, Gane EJ. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013; 368: 1878-87.
-
(2013)
N Engl J Med
, vol.368
, pp. 1878-1887
-
-
Lawitz, E.1
Mangia, A.2
Wyles, D.3
Rodriguez-Torres, M.4
Hassanein, T.5
Gordon, S.C.6
Schultz, M.7
Davis, M.N.8
Kayali, Z.9
Reddy, K.R.10
Jacobson, I.M.11
Kowdley, K.V.12
Nyberg, L.13
Subramanian, G.M.14
Hyland, R.H.15
Arterburn, S.16
Jiang, D.17
McNally, J.18
Brainard, D.19
Symonds, W.T.20
McHutchison, J.G.21
Sheikh, A.M.22
Younossi, Z.23
Gane, E.J.24
more..
-
47
-
-
84993833509
-
Minimal impact of sofosbuvir plus ribavirin on health related quality of life (HRQL) compared to pegylated inter feron plus ribavirin for chronic hepatitis C (CH-C): Results from FISSION plus positron studies
-
Younossi ZM, Stepanova M, Mir HM, Jacobson IM, Gane E, Nader F, Hunt S. Minimal impact of sofosbuvir plus ribavirin on health related quality of life (HRQL) compared to pegylated inter feron plus ribavirin for chronic hepatitis C (CH-C): results from FISSION plus positron studies. J Hepatol 2013; 58: S577-S.
-
(2013)
J Hepatol
, vol.58
-
-
Younossi, Z.M.1
Stepanova, M.2
Mir, H.M.3
Jacobson, I.M.4
Gane, E.5
Nader, F.6
Hunt, S.7
-
48
-
-
84877739274
-
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
-
Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez- Torres M, Sulkowski MS, Shiffman ML, Lawitz E, Everson G, Bennett M, Schiff E, Al-Assi MT, Subramanian GM, An D, Lin M, McNally J, Brainard D, Symonds WT, McHutchison JG, Patel K, Feld J, Pianko S, Nelson DR. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med 2013; 368: 1867-77.
-
(2013)
N Engl J Med
, vol.368
, pp. 1867-1877
-
-
Jacobson, I.M.1
Gordon, S.C.2
Kowdley, K.V.3
Yoshida, E.M.4
Rodriguez-Torres, M.5
Sulkowski, M.S.6
Shiffman, M.L.7
Lawitz, E.8
Everson, G.9
Bennett, M.10
Schiff, E.11
Al-Assi, M.T.12
Subramanian, G.M.13
An, D.14
Lin, M.15
McNally, J.16
Brainard, D.17
Symonds, W.T.18
McHutchison, J.G.19
Patel, K.20
Feld, J.21
Pianko, S.22
Nelson, D.R.23
more..
-
49
-
-
84881403455
-
Sofosbuvir for previously untreated chronic hepatitis C infection
-
Hsu CS. Sofosbuvir for previously untreated chronic hepatitis C infection: N Engl J Med 2013 Aug 15; 369(7): 678.
-
(2013)
N Engl J Med
, vol.369
, Issue.7
, pp. 678
-
-
Hsu, C.S.1
-
50
-
-
84871814966
-
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
-
Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, Hindes RG, Berrey MM. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med 2013; 368: 34-44.
-
(2013)
N Engl J Med
, vol.368
, pp. 34-44
-
-
Gane, E.J.1
Stedman, C.A.2
Hyland, R.H.3
Ding, X.4
Svarovskaia, E.5
Symonds, W.T.6
Hindes, R.G.7
Berrey, M.M.8
-
51
-
-
58149388300
-
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatmentnaive patients
-
Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatmentnaive patients. Hepatology 2008; 48: 1769-78.
-
(2008)
Hepatology
, vol.48
, pp. 1769-1778
-
-
Kuntzen, T.1
Timm, J.2
Berical, A.3
Lennon, N.4
Berlin, A.M.5
Young, S.K.6
Lee, B.7
Heckerman, D.8
Carlson, J.9
Reyor, L.L.10
Kleyman, M.11
McMahon, C.M.12
Birch, C.13
Schulze Zur Wiesch, J.14
Ledlie, T.15
Koehrsen, M.16
Kodira, C.17
Roberts, A.D.18
Lauer, G.M.19
Rosen, H.R.20
Bihl, F.21
Cerny, A.22
Spengler, U.23
Liu, Z.24
Kim, A.Y.25
Xing, Y.26
Schneidewind, A.27
Madey, M.A.28
Fleckenstein, J.F.29
Park, V.M.30
Galagan, J.E.31
Nusbaum, C.32
Walker, B.D.33
Lake-Bakaar, G.V.34
Daar, E.S.35
Jacobson, I.M.36
Gomperts, E.D.37
Edlin, B.R.38
Donfield, S.M.39
Chung, R.T.40
Talal, A.H.41
Marion, T.42
Birren, B.W.43
Henn, M.R.44
Allen, T.M.45
more..
-
52
-
-
84862664371
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.
-
(2012)
J Hepatol
, vol.57
, pp. 167-185
-
-
-
53
-
-
33749447547
-
Treating chronic hepatitis B: Today and tomorrow
-
Borgia G, Gentile I. Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006; 13: 2839-55.
-
(2006)
Curr Med Chem
, vol.13
, pp. 2839-2855
-
-
Borgia, G.1
Gentile, I.2
|